Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
This section explains why investors might choose an Equal Weighted Index, focusing on balanced exposure and straightforward rebalancing.
22,549 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
Biote's Q1 2026 earnings call reveals critical insights into revenue growth, margins, and a promising pipeline. This ...
Rigetti Computing stunned markets with a blistering rally, but behind the numbers lies a complicated story. This piec...
Insider moves always spark questions. This article unpacks EverCommerce's sells 19,200 shares, what it signals, and h...
BonkDAO’s governance proposal drained roughly $20 million in BONK from its treasury, underscoring a new risk surface ...
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
Rigetti Computing just landed $100 million in CHIPS Act funding. This article breaks down what that means for the com...
The trucking sector moves in tight cycles, and this week Knight-Swift Transportation faced a sharp price swing. Learn...
Barings BDC (BBDC) fans the flames of income investing with a steady cash-flow model. As barings (bbdc) 2025 earnings...
When a company's CFO unloads thousands of shares, investors naturally ask what it means. This analysis dives into amb...
Deribit and SignalPlus unveil The Island, a 35-day crypto trading contest with a prize pool of up to $600,000 USDC. T...